Prader-Willi syndrome

Journal of Paediatrics and Child Health

Volumn 35, Issue 4, 1999, Pages 331-334

  Couper, R T L ^a,b  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b WOMEN S AND CHILDREN S HOSPITAL   (Australia)

Author keywords

Behavioural problems; Genetics; Prader Willi syndrome

Indexed keywords

ANGER; BEHAVIOR DISORDER; CHROMOSOME 15P; CHROMOSOME DELETION; CLINICAL FEATURE; DISOMY; HUMAN; HYPERPHAGIA; MENTAL DEFICIENCY; MUSCLE HYPOTONIA; OBESITY; PRADER WILLI SYNDROME; PRIORITY JOURNAL; REVIEW;

EID: 0032837576     PISSN: 10344810     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1754.1999.00397.x     Document Type: Review

References (42)

1. 1 Prader A, Labhart A, Willi H. Ein Syndrome von adipositas, Kleinwuchs, Kryptorchismus und Oligophrenic nach myoteniertigem zustand im neugeborenanalter. Schwiez Med. Wschr. 1956; 86: 1260-1.
2. 2 Down JL. On polysarca and its treatment (London Hospital Reports 1864). In Down JL, ed. Mental Affections of Childhood and Youth 1887; 100-108. Republished by MacKeith Press, London, 1990.
3. 3 Lai L-W, Erickson RP, Cassidy SB. Clinical correlates of chromosome 15 deletions and maternal disomy in Prader-Willi syndrome. Am. J. Dis. Child. 1993; 147: 1217-23.
4. 4 Holm VA, Cassidy SB, Butler MG et al. Prader-Willi syndrome: Consensus diagnostic criteria. Pediatrics 1993; 91: 398-402.
5. 5 Butler MG, Meaney FJ. Standards for selected anthropometric measurements in Prader-Willi syndrome. Pediatrics 1991; 88: 853-60.
6. 6 Donaldson MDC, Chu CE, Cooke A, Wilson A, Greene SA, Stephenson JBP. The Prader-Willi syndrome. Arch. Dis. Child. 1994; 70: 58-63.
7. 7 Wharton RH, Wang T, Graeme-Cook F, Briggs S, Cole RE. Acute idiopathic gastric dilation with gastric necrosis in individuals with Prader-Willi syndrome. Am. J. Med. Genet. 1997; 73: 437-41.
8. 8 Fieldstone A, Zipt WB, Schwartz HC, Bernston, GG. Food preferences in Prader-Willi syndrome, normal weight and obese controls. Int. J. Obes. Relat. Metab. Disord. 1997; 21: 1046-52.
9. 9 Hart PS. Salivary abnormalities in Prader-Willi syndrome. Ann. NY Acad. Sci. 1998; 842: 125-31.
10. 10 Laurence B, Brito A, Wilkinson, J. Prader-Willi syndrome after age 15 years. Arch. Dis. Child. 1981; 56: 181-6.
11. 11 Bhargava SA, Putnam PE, Kocoshis SA, Rowe M, Hanchett JM. Rectal bleeding in Prader-Willi syndrome. Pediatrics 1996; 97: 265-7.
12. 12 Hellings JA, Warnock JK. Self injurious behaviour and serotonin in Prader-Willi syndrome. Psychopharmacol. Bull. 1994; 30: 245-50.
13. 13 Curfs LM, Wiegers AM, Sommers JR, Borghgraft M, Fryns JP. Strengths and weaknesses in the cognitive profile of youngsters with Prader-Willi syndrome. Clin. Genet. 1991; 40: 430-4.
14. 14 Jeffcoate W, Laurence B, Edwards C, Besser G. Endocrine function in Prader-Willi syndrome. Clin. Endocrinol. 1980; 12: 81-9.
15. 15 Hall JG. Genomic imprinting and its clinical implications. N. Engl. J. Med. 1992; 326: 827-9.
16. 16 Gillessen-Kaesbach G, Robinson W, Lohmann D, Kaya-Westerloh S, Passarge E, Horsthemke B. Genotype phenotype correlation in a series of 167 deletion and non-deletion patients with Prader-Willi syndrome. Hum. Genet. 1995; 96: 638-43.
17. 17 Webb T, Hardy CA, Dahlitz M, Watkiss E, Clarke D. Family studies in Prader-Willi syndrome. Genet. Couns. 1994; 5: 329-36.
18. 18 Cassidy SB, Gainey AJ, Butler MG. Occupational hydrocarbon exposure among fathers of Prader-Willi syndrome patients with and without deletions of 15q. Am J. Hum. Genet. 1989; 44: 806-10.
19. 19 Akefeldt A, Anvret M, Grandell U, Nordlinder R, Gillberg C. Parental exposure to hydrocarbons in Prader-Willi syndrome., Dev. Med. Child. Neurol. 1995; 37: 1101-9.
20. 20 Cassidy SB, Forsythe M, Heeger S et al. Comparison of phenotype between patients with Prader-Willi syndrome due to detection 15q and uniparental disomy 15. Am. J. Med. Genet. 1997; 68: 433-40.
21. 21 Oczelik T, Leff S, Robinson W et al. Small nuclear ribonucleoprotein polypeptide N (SNRPN), an expressed gene in Prader-Willi syndrome critical region. Nat. Genet. 1992; 2: 265-9.
22. 22 Werrick R, Francke U. Diagnostic test for the Prader-Willi syndrome by SNRPN expression in blood. Lancet 1996; 348: 1068-9.
23. 23 Rachmilewitz, J, Elkin, M, Looijenga, LH et al. Characterisation of the imprinted IPW gene: Allelic expression in normal and tumorigenic human tissues. Oncogene 1996; 13: 1687-92.
24. 24 Hodapp RM, Dykens EM, Marno LL. Families of children with Prader -Willi syndrome: Stress support and relations to child characteristics. J. Autism Dev. Disord. 1997; 27: 11-24.
25. 25 Selikowitz, M, Sunman, J, Prendergast, A, Wright, S. Fenfluramine in Prader-Willi syndrome: A double blind placebo controlled trial. Arch. Dis. Child. 1990; 65: 112-4.
26. 26 Kyriakides M, Silverstone T, Jeffcoate W, Laurence B. Effect of naloxone on hyperphagia in Prader-Willi syndrome. Lancet 1980; 1: 876-7.
27. 27 Zlotkin SH, Fettes IM, Stallings VA. Effects of Naltrexone, an oral 3-endorphin antoagnist, in children with Prader-Willi syndrome. J. Clin. Endorincol. Metab. 1986; 63: 1229-32.
28. 28 Abehhaim L, Moride Y, Brenot F et al. Appetite suppressant drugs and the risk of primary pulmonary hypertension. N. Engl. J. Med. 1996; 335: 609-16.
29. 29 Zipf WB, O'Dorisio TM, Bernston, GG. Short term infusion of pancreatic polypeptide: Effect on children with Prader-Willi syndrome. Am. J. Clin. Nutr. 1990; 51: 162-6.
30. 30 Lee PD, Hwu K, Henson H et al. Body composition studies in Prader-Willi syndrome: Effects of growth hormone therapy. Basic Life Sci. 1993; 60: 201-5.
31. 31 Fonkalsrud EW, Bray G. Vagotomy for treatment of obesity in Prader-Willi syndrome. J. Pediatr. Surg. 1981; 16: 888-9.
32. 32 Miyata M, Dousei T, Harada T et al. Metabolic changes following gastroplasty in Prader-Willi syndrome - a case report. Japn J. Surg. 1990; 20: 359-64.
33. 33 Dech B, Budow L, The use of fluoxetine in an adolescent with Prader-Willi syndrome. J. Am. Acad, Child Adolesc. Psychiatry 1991; 30: 298-302.
34. 34 Weigle DS, Gunter SL, Kuijper JL, Leonetti DL, Boyko EJ, Fujimoto WY. Effect of regional fat distribution and Prader-Willi syndrome on plasma leptin levels. J. Clin. Endocrinol. Metab. 1997; 82: 566-70.
35. 35 Schoeller D, Levitsky L, Bandini L, Dietz W, Walczak A. Energy expenditure and body composition in Prader-Willi syndrome. Metabolism 1988; 37: 115-20.
36. 36 Kaufman H, Overton G, Leggott J. Clericuzio C, Prader-Willi syndrome: Effect of group home placement on obese patients with diabetes. South Med. J. 1995; 88: 182-4.
37. 37 Richards A, Quaghebeur G, Clift S, Holland A. Dahlitz M. Parkes D. The upper airway and sleep apnoea in Prader-Willi syndrome. Clin. Otolaryngol, 1994; 19: 193-7.
38. 38 Schulter B, Buschatz D, Trowitzch E, Aksau F. Andler W. Respiratory control in children with Prader-Willi syndrome. Eur. J. Pediatr. 1997; 156: 65-8.
39. 39 Skorzewska A. Lal S, Waserman J, Guyda H. Abnormal food seeking behaviour after surgery for craniopharyngioma. Neuropsychobiology 1989; 21: 17-20.
40. 40 Dykens EM, Hodapp RM, Walsh K, Nash LJ. Adaptive and maladaptive behaviour in Prader-Willi syndrome. J. Am. Acad. Child Adolesc. Psychiatry 1992; 31: 1131-6.
41. 41 Joseph B, Overmeir JB, Thompson T. Food and non-food related differential outcomes in equivalence learning by adults with Prader-Willi syndrome. Am. J. Ment. Retard. 1997; 101: 374-86.
42. 42 Warnock JK, Kestenbaum T. Pharmacologic treatment of severe skin-picking behaviours in Prader-Willi syndrome. Two case reports. Arch. Dematol 1992; 128: 1623-5.